A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
Medical College of Wisconsin
Instituto do Cancer do Estado de São Paulo
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Emory University
Emory University
Novartis
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
Children's Oncology Group
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)